Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome.
Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome.
复制标题
对乙酰氨基酚过量且预后不良的患者的血清线粒体生物标志物和损伤相关分子模式较高。
DOI:
10.1002/hep.27265
复制
发表时间:
2014-10
期刊:
影响因子:
13.5
通讯作者:
Jaeschke, Hartmut
中科院分区:
文献类型:
--
作者:
McGill, Mitchell R.;Staggs, Vincent S.;Sharpe, Matthew R.;Lee, William M.;Jaeschke, Hartmut
Acetaminophen (APAP) overdose is a major cause of acute liver failure (ALF). Numerous studies have shown that APAP hepatotoxicity in mice involves mitochondrial dysfunction, and recent data suggest this is also the case in humans. We have previously shown that glutamate dehydrogenase (GDH), mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) fragments can be measured in circulation of overdose patients as mechanistic biomarkers of mitochondrial damage and damage-associated molecular patterns. In the present study, our goal was to determine if these biomarkers are higher in serum from non-survivors of APAP-induced ALF (AALF) compared with survivors. GDH, mtDNA and nDNA fragments were measured in serum from AALF patients who did (n = 34) or did not (n = 35) recover. Importantly, all three were significantly increased in patients who died compared with those who survived (GDH: 450±73 vs. 930±145 U/L; mtDNA: 21±6 vs. 48±13 and 33±10 vs. 43±7 ng/mL for two different genes; nDNA fragments: 148±13 vs. 210±13 % of control). Receiver operating characteristic (ROC) curve analyses revealed that nDNA fragments, GDH and mtDNA were predictive of outcome (AUC, study admission: 0.73, 0.70 and 0.71 or 0.76, respectively, p < 0.05; AUC, time of peak ALT: 0.78, 0.71 and 0.71 or 0.76, respectively, p < 0.05) and the results were similar to those from the model for end-stage liver disease (MELD) (AUC, peak MELD: 0.77, p < 0.05). Our data suggest that patients with more mitochondrial damage are less likely to survive, demonstrating that mitochondria are central in the mechanisms of APAP hepatotoxicity in humans. Clinically, serum nDNA fragments, GDH and mtDNA could be useful as part of a panel of biomarkers to predict patient outcome.
登录
查看更多内容
影响因子:
13.5
作者:
Antoine, Daniel J.;Dear, James W.;Lewis, Philip Starkey;Platt, Vivien;Coyle, Judy;Masson, Moyra;Thanacoody, Ruben H.;Gray, Alasdair J.;Webb, David J.;Moggs, Jonathan G.;Bateman, D. Nicholas;Goldring, Christopher E.;Park, B. Kevin
通讯作者:
Park, B. Kevin
影响因子:
4.1
作者:
Chen, Chi;Krausz, Kristopher W.;Shah, Yatrik M.;Idle, Jeffrey R.;Gonzalez, Frank J.
通讯作者:
Gonzalez, Frank J.
影响因子:
25.7
作者:
Antoine, Daniel J.;Jenkins, Rosalind E.;Dear, James W.;Williams, Dominic P.;McGill, Mitchell R.;Sharpe, Matthew R.;Craig, Darren G.;Simpson, Kenneth J.;Jaeschke, Hartmut;Park, B. Kevin
通讯作者:
Park, B. Kevin
影响因子:
5.9
作者:
Jaeschke H;McGill MR;Ramachandran A
通讯作者:
Ramachandran A
影响因子:
13.5
作者:
Kon, K;Kim, JS;Lemasters, JJ
通讯作者:
Lemasters, JJ